Global Blood Therapeutics Inc.

(GBT) Trade

By |

Profile

Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.

Contact Information

Website: www.gbt.com
Email: investor@globalbloodtx.com
Main Phone: +1 650 741-7700
Address: 171 Oyster Point Boulevard
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Ted W. Love
Employees: 147
NAICS: Medicinal and Botanical Manufacturing (325411)
$ 49.95 $ 2.00 (4.17%)
Last Price 49.95 Change $ 2.00 Change % 4.17 Tick N/A
Bid 49.65 Bid Size 100.00 Ask 50.35 Ask Size 100.00
Open 48.45 High 51.70 Low 47.85 Prev Close 47.95
Last Trade Volume 1.6 mi 52 Wk Hi 68.05 52 Wk Low 26.10
Market Cap 2.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 52,053,294.00 EPS (TTM) -3.26 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 15 141
Number of Buys 9 75
Number of Sells 6 66
Net Activity -4800 104148
Last 10 Buys Shares
Edelman Joseph 1,000
John Schembri 1,000
Eleanor L. Ramos 1,000
Hing Sham 1,000
Peter Radovich 1,000
Mark L. Perry 1,000
Ted W. Love 1,000
Deval L. Patrick 1,000
John Schembri 1,000
Eleanor L. Ramos 1,000
Last 10 Sell Shares
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Lesley Ann Calhoun 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Peter Radovich 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 83 83 83 83
Low Target Price Estimate 59 59 59 59
Mean Target Price Estimate 73 73 73 73
Standard Deviation 6.16 6.16 6.16 6.16
Date of Most Recent Estimate 05/24/18 05/24/18 05/22/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 10 9 9 10
Moderate Buy 1 1 1 2
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.27 1.27 1.13